Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Shire to augment Cambridge presence
by Michael McCo
November 28, 2016
| A version of this story appeared in
Volume 94, Issue 47
Shire will expand its operations in Cambridge, Mass., by establishing a rare disease “innovation hub” in Kendall Square. The firm has leased a 32,000 m2 building at 500 Kendall Street, adjacent to space it currently occupies at 650 Kendall Street. Last year, Shire closed a facility in Pennsylvania and set up its U.S. headquarters in Lexington, Mass. The British company says it employs more than 3,000 people in Massachusetts and has nearly 400 job openings in the state.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter